Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07

被引：0

作者：

Yoshihiro Kakeji

Kazuhiro Yoshida

Yasuhiro Kodera

Mitsugu Kochi

Takeshi Sano

Wataru Ichikawa

Sang-Woong Lee

Kazushige Shibahara

Toshio Shikano

Masato Kataoka

Atsushi Ishiguro

Hitoshi Ojima

Yoshinori Sakai

Nobuyuki Musha

Tsunenobu Takase

Taisei Kimura

Masahiro Takeuchi

Masashi Fujii

机构：

[1] Kobe University Graduate School of Medicine,Division of Gastrointestinal Surgery, Department of Surgery

[2] Gifu University,Department of Surgical Oncology

[3] Nagoya University,Department of Gastroenterological Surgery

[4] Nihon University Itabashi Hospital,Department of Digestive Surgery

[5] Cancer Institute Hospital,Gastroenterological Surgery

[6] Showa University Fujigaoka Hospital,Division of Medical Oncology

[7] Osaka Medical College,Department of General and Gastroenterological Surgery

[8] Toyama Red Cross Hospital,Department of Surgery

[9] Yokkaichi Municipal Hospital,Department of Surgery

[10] National Hospital Organization,Department of Surgery

[11] Nagoya Medical Center,Department of Medical Oncology

[12] Teine Keijinkai Hospital,Department of Gastrointestinal Surgery

[13] Gunma Prefectural Cancer Center,Department of Gastrointestinal Medicine

[14] Tsuchiura Kyodo General Hospital,Department of Surgery

[15] Saiseikai Niigata Hospital,Department of Surgery

[16] Kainan Hospital,Department of Surgery

[17] Seirei Mikatahara General Hospital,Department of Clinical Medicine, School of Pharmacy

[18] Kitasato University,undefined

来源：

Gastric Cancer | 2022年 / 25卷

关键词：

S-1; Docetaxel; Gastric cancer; Adjuvant chemotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：188 / 196

页数：8

共 50 条

[21] S-1 plus docetaxel: a safe and effective chemotherapy regimen for stage III gastric cancer
Diao, Feiyu
Lai, Wei
Chu, Zhonghua
CANCER COMMUNICATIONS, 2019, 39 (01)
[22] Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study (vol 26, 1063, 2023)
Kodera, Yasuhiro
Yoshida, Kazuhiro
Kochi, Mitsugu
Sano, Takeshi
Ichikawa, Wataru
Kakeji, Yoshihiro
Sunakawa, Yu
Takeuchi, Masahiro
Fujii, Masashi
GASTRIC CANCER, 2024, 27 (05) : 1157 - 1157
[23] Feasibility and predictive factors on the completion of docetaxel plus S-1 adjuvant chemotherapy in pathological stage III gastric cancer
Terayama, Masayoshi
Ohashi, Manabu
Yamaguchi, Kensei
Takahari, Daisuke
Makuuchi, Rie
Hayami, Masaru
Ida, Satoshi
Kumagai, Koshi
Sano, Takeshi
Nunobe, Souya
ANNALS OF GASTROENTEROLOGICAL SURGERY, 2025, 9 (01): : 60 - 68
[24] Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer
Takahari, Daisuke
Hamaguchi, Tetsuya
Yoshimura, Kenichi
Katai, Hitoshi
Ito, Seiji
Fuse, Nozomu
Konishi, Masaru
Yasui, Hirofumi
Terashima, Masanori
Goto, Masahiro
Tanigawa, Nobuhiko
Shirao, Kuniaki
Sano, Takeshi
Sasako, Mitsuru
GASTRIC CANCER, 2014, 17 (02) : 383 - 386
[25] Phase III study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013).
Yamada, Yasuhide
Boku, Narikazu
Mizusawa, Junki
Iwasa, Satoru
Kadowaki, Shigenori
Nakayama, Norisuke
Azuma, Mizutomo
Sakamoto, Takeshi
Shitara, Kohei
Okuno, Tatsuya
Chin, Keisho
Nozaki, Akira
Nakamura, Masaki
Hara, Hiroki
Katayama, Hiroshi
Fukuda, Haruhiko
Yoshikawa, Takaki
Sano, Takeshi
Sasako, Mitsuru
Terashima, Masanori
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[26] Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer
Daisuke Takahari
Tetsuya Hamaguchi
Kenichi Yoshimura
Hitoshi Katai
Seiji Ito
Nozomu Fuse
Masaru Konishi
Hirofumi Yasui
Masanori Terashima
Masahiro Goto
Nobuhiko Tanigawa
Kuniaki Shirao
Takeshi Sano
Mitsuru Sasako
Gastric Cancer, 2014, 17 : 383 - 386
[27] Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
Ryohei, Kawabata
Kazumasa, Fujitani
Shigeyuki, Tamura
Yutaka, Kimura
Hiroshi, Imamura
Junya, Fujita
Jin, Matsuyama
Shohei, Iijima
Shugo, Ueda
Yukinori, Kurokawa
Daisuke, Sakai
Toshio, Shimokawa
Toshimasa, Tsujinaka
Hiroshi, Furukawa
Taroh, Satoh
ANNALS OF ONCOLOGY, 2017, 28
[28] Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
Ishigami, Hironori
Fujiwara, Yoshiyuki
Fukushima, Ryoji
Nashimoto, Atsushi
Yabusaki, Hiroshi
Imano, Motohiro
Imamoto, Haruhiko
Kodera, Yasuhiro
Uenosono, Yoshikazu
Amagai, Kenji
Kadowaki, Shigenori
Miwa, Hiroto
Yamaguchi, Hironori
Yamaguchi, Takuhiro
Miyaji, Tempei
Kitayama, Joji
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1922 - +
[29] S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Koizumi, Wasaburo
Narahara, Hiroyuki
Hara, Takuo
Takagane, Akinori
Akiya, Toshikazu
Takagi, Masakazu
Miyashita, Kosei
Nishizaki, Takashi
Kobayashi, Osamu
Takiyama, Wataru
Toh, Yasushi
Nagaie, Takashi
Takagi, Seiichi
Yamamura, Yoshitaka
Yanaoka, Kimihiko
Orita, Hiroyuki
Takeuchi, Masahiro
LANCET ONCOLOGY, 2008, 9 (03): : 215 - 221
[30] An update on the randomized phase III POST trial: S-1 based doublet as an adjuvant chemotherapy for curatively resected stage III gastric cancer
Lee, Choong-kun
Jung, Minkyu
Kim, Hyo Song
Jung, Inkyung
Shin, Dong Bok
Kang, Seok Yun
Zang, Dae Young
Kim, Ki Hyang
Lee, Moon Hee
Kim, Bong-Seog
Lee, Kyung Hee
An, Ji Yeong
Kim, Hyoung-Il
Cheong, Jae-Ho
Hyung, Woo Jin
Noh, Sung Hoon
Chung, Hyun Cheol
Rha, Sun Young
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

← 1 2 3 4 5 →